Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Microtest, Texcel to offer combo product testing
July 2007
SHARING OPTIONS:

AGAWAM, Mass.—Microtest Laboratories and Texcel Medical have announced a strategic alliance to provide pharmaceutical manufacturers and biotechnology companies with a competitive advantage when developing the latest breed of "combination products."
 
"The combination products market is booming. Yet, many pharmaceutical companies are struggling to manage the convergence of devices and drugs or biologics and the host of unique FDA testing guidelines, practices and regulations that such products require," says Steven Richter, Ph.D., president of Microtest. "For such firms, outsourcing is the solution—provided that the arrangement is struck with the right partner.  This is the strategy behind the Microtest/Texcel alliance."
 
An estimated 30 percent of products under development this year are combo products—consisting of medical devices embedded with pharmaceutical or biologics components. The market is forecast to reach approximately $9.5 billion in 2009.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.